CKD-333 clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How each study uses CKD-333 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2020 (3)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses CKD-333 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy VolunteersStatus unknownPhase 1Chong Kun Dang PharmaceuticalNCT04627207Written as CKD-333 1 Tab
- Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy VolunteersStatus unknownPhase 1Chong Kun Dang PharmaceuticalNCT04611932Written as CKD-333 Tab.
- Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy VolunteersStatus unknownPhase 1Chong Kun Dang PharmaceuticalNCT04478097Written as CKD-333 Tab.
- Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male AdultsStatus unknownPhase 1Chong Kun Dang PharmaceuticalNCT03849287Written as CKD-333, formula I
- Pharmacokinetics and Safety Profile of CKD-333CompletedPhase 1Chong Kun Dang PharmaceuticalNCT03659149Written as CKD-333 formulation I